Sun Pharma to buy 60 percent stake in Vivaldis Health and Foods for Rs 143 crore
Advertisement
Mumbai: Pharma major, Sun Pharmaceutical Industries Limited, has entered into an agreement to acquire 60 percent shareholding in Vivaldis Health And Foods Private Limited from its existing shareholders with the remaining 40 percent shareholding to be acquired in the future as per certain terms and conditions.
"The cost of acquisition is Rs 143.30 crores subject to customary closing adjustments for 60 percent shareholding," the company stated in a recent BSE filing. The company expects to complete the said acquisition by the end of May 2023.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.